Regeneron Pharmaceuticals, Inc. (0R2M.L) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Regeneron Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 17.97x |
| P/B Ratio | 2.59x |
| P/S Ratio | 5.64x |
| Profitability | |
| Gross Margin | 86.3% |
| Operating Margin | 25.7% |
| Net Margin | 31.4% |
| EBITDA Margin | 29.6% |
| Liquidity | |
| Current Ratio | 4.77x |
| Quick Ratio | 4.22x |
| Leverage | |
| Debt/Equity | 0.09x |
YoY = year-over-year change. Source: FMP..